Dietary Protein Patterns for Parkinson's Disease

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical diagnosis of idiopathic PD for 5 or more years

45 years or older

Must not have

Untreated sleep apnea

Known narcolepsy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity.

Awards & highlights

No Placebo-Only Group

Summary

This trial will study the effects of different dietary protein patterns on people with Parkinson's disease.

Who is the study for?

This trial is for people over 45 with Parkinson's Disease diagnosed at least 5 years ago, who are on stable levodopa treatment and have motor fluctuations. It's not for those on special diets, with renal disease, deep brain stimulation, narcolepsy, untreated sleep apnea or any condition that might interfere with the study.

What is being tested?

The study tests how different protein diets affect muscle health and medication effectiveness in Parkinson's patients. One group will follow a Protein Redistribution Diet while another will maintain a consistent protein intake to see which is better.

What are the potential side effects?

Since this trial involves dietary changes rather than medications, side effects may include digestive discomfort or changes in energy levels as the body adjusts to new eating patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Parkinson's disease for 5 or more years.

Select...

I am 45 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have sleep apnea that has not been treated.

Select...

I have been diagnosed with narcolepsy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 5 weeks. total score ranges from 0-260 with higher scores indicating greater symptom severity. for reporting.